VitaDX
Cancer diagnosis using artificial intelligence
VitaDX is a deeptech company that develops and commercializes cancer diagnostic solutions, combining image analysis and artificial intelligence applied to cytology with its own patented VisioCyt® technology.
- Rennes & Paris, France
-
Founded in 2015
Solutions serving patients
Its mission is to develop innovative and high-performance solutions with a significant impact on healthcare systems, benefiting the largest possible number of patients.
After several years of development and a prospective multicenter clinical study, its first solution, CE IVDR-marked VisioCyt® Bladder, enables the diagnosis and follow-up of bladder cancer from a simple urine sample.
Other devices are currently in development, including for bladder cancer screening and thyroid cancer diagnosis.
Our values
Innovation
Innovation drives our approach, with a commitment to go beyond standards and explore new avenues. We continuously invest in R&D to stay at the forefront and tackle technical challenges.
Accessibility
We are committed to making our technologies accessible to as many people as possible, while promoting a horizontal management approach that values initiative, responsibility, and each individual’s role in our collective success.
Human-centered
Guided by the impact we can have on patients’ lives, we create solutions that enhance their well-being. We prioritize people above all and unite our efforts around a common goal. More than a team, we form a community.
Our team
Our team is made up of scientists, engineers, clinicians, and healthcare professionals dedicated to VitaDX’s mission. Together, we work to push the boundaries of medical technology and improve patients’ lives.
Fabrice Beauchêne
CEO
Florence Fournier
Chief Finance Officer
Raphaël Moustié
Chief Quality Officer
Charlotte Guinard
Chief Of Staff
Thomas Le Naour
Chief Information Officer
Florent Couziné-Devy
Chief Scientific Officer
Thomas Aubry
Chief Technology & Product Officer
Kathleen Tremaudan
Scientific & Technical Manager
Laurent Khairallah
Promotion & Distribution Manager
Lucie Paget
Marketing & Communications Manager
Chaïma Sadki
HR & Administrative Operations Manager
Riadh Fezzani
Senior Machine Learning Engineer
Simon Thomine
Machine Learning Engineer
Ariel Auque
Machine Learning Engineer
Imen Chemkhi
Research engineer
Julien Weber
Medical Software
Engineer
Ilyes Benabdallah
Medical Software
Engineer
Thomas Bourgoin
Full Stack Software Engineer
News
All our news
Don’t miss any VitaDX news: innovations, projects, and key milestones in our development.
- Date: 6 juin 2025
La HAS donne un avis favorable à la prise en charge dérogatoire de VisioCyt® Bladder
La HAS donne un avis favorable à la prise en charge dérogatoire de VisioCyt® Bladder, une avancée majeure pour la surveillance des tumeurs de la…
Lire l'article
- Date: 1 mai 2025
Un nouveau registre national pour une meilleure prise en charge et moins d’examens invasifs !
Face à une pathologie fréquente et encore trop méconnue, l’Association Française d’Urologie (AFU) déploie un registre national inédit dédié aux tumeurs de la vessie non…
Lire l'article
- Date: 25 mars 2025
L’IA au service de la santé : un nouveau paradigme pour le diagnostic du cancer et la prise en charge des patients
L’intelligence artificielle (IA) bouleverse le paysage de la santé, notamment dans le secteur du diagnostic médical. Elle ouvre la voie à une médecine plus prédictive…
Lire l'article
Join us